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O B J E C T I V E S Our aim was to determine whether serial contrast-enhanced cardiac magnetic
resonance (CE-CMR) is useful for the characterization of tissue signal changes within the coronary vessel
wall in patients after acute myocardial infarction (AMI).
B A C KG ROUND Inﬂammation plays a key role in the development of AMI. CE-CMR of the vessel
wall has been found useful for the characterization of inﬂammatory tissue signal changes in patients
with carotid artery stenosis, giant cell arteritis, or Takayasu’s arteritis; however, it has never been serially
performed in the coronary artery wall in patients with acute and chronic myocardial infarction using a
gadolinium-based contrast medium and compared with systemic markers of inﬂammation.
METHOD S CE-CMR using a T1-weighted 3-dimensional gradient echo inversion recovery sequence
of the coronary artery wall and 0.2 mmol/kg of gadolinium-diethylenetriaminepentaacetic acid was
performed in 10 patients with AMI 6 days and 3 months after coronary intervention and in 9 subjects
without coronary artery disease on invasive coronary angiography. Contrast-to-noise ratio (CNR) within
the coronary artery wall was quantiﬁed in comparison with blood signal.
R E S U L T S Patients with AMI demonstrated a signiﬁcantly increased coronary vessel wall enhance-
ment 6 days after infarction compared with normal subjects (CNR 7.8  4.4 vs. 5.3  3.2, p  0.001).
Three months after infarction, CNR decreased to 6.5  4.7 (p  0.03). This decrease paralleled declines
in C-reactive protein. Angiographically normal segments showed no contrast changes, but CNR
signiﬁcantly decreased in stenotic segments, from 10.9  3.8 to 6.8  5.0 (p  0.002), resulting in a
reduction of enhanced segments from 70% to 25% (p  0.01).
CONC L U S I O N S Serial CE-CMR identiﬁed changes in spatial extent and intensity of coronary
contrast enhancement in patients after AMI. This technique may be useful for the characterization of
transient coronary tissue signal changes, which may represent edema or inﬂammation during the
post-infarction phase. In addition, CE-CMR may offer the potential for visualization of inﬂammatory
activity in atherosclerosis associated with acute coronary syndromes. (J Am Coll Cardiol Img 2009;2:
580–8) © 2009 by the American College of Cardiology Foundation
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581therosclerotic cardiovascular disease is the
leading cause of mortality and morbidity in
developed countries (1). Inflammation
plays a key role in the initiation, progres-
ion, and complication of atherosclerosis (2) and is
losely linked to coronary plaque rupture, the un-
erlying pathogenesis of acute coronary syndromes
ACS) (3). Growing evidence suggests that the
ecisive factor determining plaque vulnerability is
laque composition and inflammatory activity
ather than the degree of luminal narrowing (4).
See page 589
ngiography often underestimates the true burden
f disease and does not provide any information
ith regard to plaque activity. In addition, high-risk
laques of the coronary arteries are often associated
ith positive lumen preserving remodeling (5) and,
herefore, a priori detection by X-ray angiography
r scintigraphic techniques is ambiguous.
Cardiac magnetic resonance (CMR) has shown
reat promise for noninvasive imaging and character-
zation of the coronary atherosclerotic plaque (6).
ative coronary CMR vessel wall imaging has pro-
ided assessment of arterial remodeling in patients
ith coronary artery disease (CAD) (7–9), but wide-
pread use of this technique is limited by long scan
imes and the need for high spatial resolution.
Contrast-enhanced CMR (CE-CMR) using ex-
racellular gadolinium contrast agents represents an
lternative imaging approach that may offer mor-
hological as well as functional assessment of ath-
rosclerotic plaque formation. This technique is
ow insensitive and relatively fast and therefore
otentially more robust than noncontrast-enhanced
MR vessel wall imaging. Furthermore, the imag-
ng task is reduced to detect the presence or absence
f contrast uptake, thereby lowering spatial resolu-
ion requirements. CE-CMR has been found useful
or the characterization of fibrous plaque tissue and
eovascularization in patients with advanced ca-
otid artery stenosis (10–13). Preliminary data in
atients with stable CAD have demonstrated that
E-CMR provides selective plaque visualization in
he major coronary arteries in comparison to mul-
idetector computed tomography (14,15).
Because extracellular contrast agents are nonspe-
ific, this technique also allows for the character-
zation of acute inflammation within the vessel wall,
s has been demonstrated in giant cell arteritis or
akayasu’s arteritis (16,17). Whether coronary en-
ancement may also reflect an inflammatory com- gonent is not known, as ACS patients have not
een examined.
In this study, we sought to evaluate coronary
E-CMR vessel wall imaging in patients with
cute myocardial infarction (AMI). To assess po-
ential changes of atherosclerotic plaque signal,
E-CMR was serially performed during the post-
nfarct phase.
E T H O D S
tudy populations. We prospectively enrolled 10
atients (9 men, age 56.5  4.9 years) with AMI
ith an onset of symptoms 48 h. Diagnosis of
MI was based on the presence of acute chest pain
asting for at least 20 min, characteristic electrocar-
iographic changes (ST-segment elevation or de-
ression) as well as elevation of troponin T. All
atients underwent successful percutaneous coro-
ary intervention with stenting (drug-
luting stent) of the infarct-related artery
n the day of admission. To be included,
atients had to be hemodynamically stable
nd to have no contraindication to CMR.
ll patients were examined twice by
MR, 6  3 days and 93  40 days after
eperfusion. During this period, no patient
ad clinical evidence of recurrent myocar-
ial infarction, and all received medical
herapy consisting of aspirin, clopidogrel,
eta-blocker, angiotensin-converting en-
yme inhibitor, and statins. Nine subjects
5 men, age 61.7  9.5 years) without
ngiographically detectable CAD served
s controls. CMR in the control group was
erformed 3  2 days after elective X-ray coronary
ngiography. The study protocol was reviewed and
pproved by the local ethics committee for clinical
nvestigations. Written informed consent was ob-
ained before inclusion in the study.
mage acquisition. All subjects were scanned in the
upine position on a 1.5-T magnetic resonance
canner (Gyroscan Achieva, Philips Medical Sys-
ems, Best, the Netherlands) with a 5-element
ardiac synergy coil and an advanced cardiovascular
oftware package (R11, Philips Medical Systems).
Before imaging, 0.2 mmol/kg of gadolinium-
iethylenetriaminepentaacetic acid (DTPA) (Magne-
ist, Bayer-Schering, Berlin, Germany) was adminis-
ered intravenously using a bolus injection. Coronary
MR of the right and left system was then performed
sing a previously described free-breathing navigator-
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582-dimensional (3D) balanced steady-state free preces-
ion coronary CMR sequence (18). Imaging parame-
ers included field of view  320  320 mm, matrix
256 256, acquired in-plane resolution 1.25
.25 mm, reconstructed slice thickness  1.5 mm
acquired: 3 mm), acquisition window  80 to 100
s, repetition time/echo time  4.2 ms/2.1 ms, flip
ngle 110°, startup cycles 5, and number of slices
24. Immediately after coronary lumen imaging,
E-CMR coronary artery wall imaging (targeted slab
cquisition) was performed using a T1-weighted 3D
radient echo inversion recovery sequence (3D IR
FE) (19,20). Because of scout scans, including cor-
nary lumen scans, the time delay between contrast
njection and CE-CMR was approximately 30 to 40
in. Imaging parameters, including imaging plane
nd voxel size, were identical to the coronary CMR
equence, except for TR/TE  6.1/1.9 ms, flip angle
30°, and a nonselective inversion radiofrequency
ulse instead of T2 preparation for magnetization
reparation. The patient-specific inversion time
range 250 to 280 ms) was adjusted to null blood
using a region of interest to determine the most
ccurate value) using a Look Locker sequence. Owing
o time constraints, only post-contrast imaging was
erformed. However, previous studies showed no
nhancement before contrast injection in healthy sub-
ects (15).
mage analysis. CE-CMR and X-ray coronary an-
iography were compared according to an
-segment model (Fig. 1). For CE-CMR, multi-
lanar reformatted images were analyzed by a
linded observer (A.J.) who was unaware of the
atient’s clinical and X-ray angiographic data. Seg-
RCA
1
2
3
Figure 1. Segmental Model for Comparison of Coronary Contrast-En
The coronary vessel tree was subdivided into 8 segments. For segm
from coronary origin. The right coronary artery (RCA) was analyzed
left main artery (5), the left anterior descending (6 and 7), and theents with stents (metallic artifacts) and distal to otents (local field disturbance and Faraday shielding
ffect with inadequate blood nulling) were excluded
rom analysis. A contour was manually drawn in the
scending aorta to determine blood signal intensity
SI), and coronary wall SI was assessed in each
egment and quantified with the use of dedicated
ost-processing software (21). Contrast enhance-
ent within coronary or aortic vessel wall segments
as defined as the contrast-to-noise ratio (CNR)
etween coronary or aortic wall signal (SIwall) and
ortic blood signal: CNR (SIwall SIblood)/noise.
oise was determined in a region of interest placed
entrally to the patient’s chest wall.
The X-ray coronary angiography was performed
sing standard techniques with multiple projec-
ions. Coronary angiograms were evaluated by 2
xperienced cardiologists (T.I. and M.K.) who were
linded to clinical data and CMR results. The
resence of lumen narrowing was classified visually
y consensus on a segment-by-segment basis using
he following scheme: 0  none, 1  1% to 24%,
 25% to 50%, and 350% stenosis. Coronary
rtery stenosis was defined by a segment score of
2. Suppression of coronary blood signal facilitated
ood delineation of the enhancing coronary vessel
all segments. To highlight the anatomic relation-
hip between contrast enhancement and morphol-
gy, images were fused in a way similar to positron
mission tomography/computed tomography (Figs.
D, 2H, and 2L).
tatistical analysis. For statistical analysis, SPSS soft-
are (SPSS version 12.0, SPSS Inc., Chicago, Illinois)
as used. Results are expressed as mean  SD. An
npaired Student t test was applied for the comparison
5
6
711
13
LCA
ed Cardiac Magnetic Resonance and X-Ray Coronary Angiography
identiﬁcation, segments were pre-deﬁned according to distance
segments (1, 2, and 3), the left coronary artery (LCA) within the
mﬂex artery (11 and 13).hanc
ent
in 3f continuous variables between subjects without and
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583atients with CAD. For serial assessment of CNR in
atients with CAD, the paired Student t test was
sed. The Kruskal-Wallis test was used for the corre-
ation of CNR according to severity of coronary
tenosis. Categorical variables were compared by
isher exact test. Receiver-operating characteristic
ROC) analysis was performed in AMI patients at
aseline to define the threshold for increased coronary
ontrast enhancement (CNR) by CE-CMR accord-
ng to the presence of coronary artery stenosis (25%)
n X-ray angiography. All tests were 2-sided, and a
alue of p 0.05 was considered to indicate statistical
ignificance.
E S U L T S
atient characteristics. Clinical and angiographic
haracteristics of the study populations are summa-
Figure 2. CMR Findings
Control population: data are shown from a 52-year-old subject with
(B) coronary magnetic resonance angiography (MRA) without contr
CMR). To highlight the anatomic relationship between contrast enh
positron emission tomography/computed tomography (D). Data are
and luminal irregularities (arrow) of the RCA on X-ray angiography
conﬁrms this ﬁnding; and CE-CMR (G, H) revealed diffuse strong co
ments. Note the excellent suppression of blood signal (dotted whit
same patient with a stent in the proximal left anterior descending a
MRA, demonstrating a signal void at the location of the stent (arro
to the stent and in the proximal left circumﬂex artery (LCX) (dottedized in Table 1. In patients with AMI, infarct was cocated in the anterior (n 4), inferior (n 4), and
ateral (n  2) wall. Eighty percent showed ST-
egment elevation at presentation, and 90% were
lassified according to Killip class 1 criteria; 1
atient met Killip class 2 criteria. During AMI,
nflammatory markers were significantly increased
ompared with subjects without CAD (Table 1).
lthough C-reactive protein (CRP) levels at base-
ine were elevated in 9 of 10 infarct patients, all
xcept 1 patient showed normal levels at follow-up.
E-CMR analysis. CMR scans were successfully per-
ormed in all subjects. In controls, contrast en-
ancement within the coronary vessel wall was
ssessable in 71 of 72 (98.6%) of the segments. The
istal part of the right coronary artery (segment 3)
as not visible on CE-CMR in 1 subject. In
atients with AMI, 20% (16 of 80) of the segments
ormal right coronary artery (RCA) on (A) X-ray angiography and
ptake on (C) contrast-enhanced cardiac magnetic resonance (CE-
ment and morphology, images were fused in a way similar to
wn from a 56-year-old patient with anterior myocardial infarction
Coronary MRA (F) 10 days after acute myocardial infarction (AMI)
st enhancement (white arrow) in the corresponding vessel seg-
rows). Data are shown from the left coronary artery system of the
y (LAD) on (I) X-ray angiography and (J) corresponding coronary
n CE-CMR, focal enhancement (K, L) can be observed proximal
ows). LV  left ventricle.a n
ast u
ance
sho
(E).
ntra
e ar
rter
w). Oould not be analyzed by CE-CMR. The most
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584ommon reason was the presence of implanted
tents (15 of 80), and in 1 patient, the distal right
oronary artery segment was not detectable.
aseline CE-CMR in AMI patients. Six days after AMI,
he strength of coronary contrast enhancement as
p<0.001
p<0.03
p<0.1
AMI Baseline AMI Follow-up No CAD
Contrast-to-Noise Ratio at Baseline and Follow-Up
n of the average contrast-enhanced cardiac magnetic resonance
hancement within the coronary artery wall in patients 6 days
and 3 months (follow-up) after acute myocardial infarction (AMI)
acteristics
No CAD (n  9) AMI (n  10)
61.7  9.5 56.5  4.9
44.4 10.0
ia 11.1 40.0
66.7 80.0
11.1 10.0
44.4 50.0
D 22.2 40.0
0.01 3.4  2.2*
g/ l 5.3  0.6 8.6  1.9*
s, g/ l — 7.6  1.7*
rotein, mg/dl 0.1  0.3 2.6  1.7*
protein, mg/dl — 0.8  2.5
% (n)
83.3 (60/72) 36.2 (29/80)
16.7 (12/72) 23.8 (19/80)
% — 22.5 (18/80)
— 2.5 (2/80)
— 15.0 (12/80)
on of acute myocardial infarction (AMI) versus no coronary artery disease (CAD).c
in subjects without coronary artery disease (CAD).efined by the CNR averaged over all segments was
.8  4.4 and was significantly higher compared
ith normal subjects (5.3  3.2, p  0.001) (Figs.
and 3). Coronary contrast enhancement signifi-
antly correlated with the angiographic severity of
umen narrowing (p  0.001). Coronary segments
ith stenosis had a significantly increased CNR
ompared with nonstenotic segments (CNR 10.9
.8 vs. 6.4  3.9, p  0.001). Based on an ROC
urve analysis, a CNR threshold of 9.7 (hyperen-
ancement) was determined for detection of ste-
otic coronary segments by CE-CMR (area under
he curve 0.81, sensitivity 70%, specificity 86%).
his threshold was used to distinguish between
tenotic and nonstenotic segments. For the de-
cending aortic vessel wall, a mean CNR of 12.2 
.0 was measured.
ollow-up CE-CMR in AMI patients. Three months
fter AMI, coronary CNR was 6.5  4.7, and was
educed as compared with 6-day data (p  0.03)
Figs. 4 and 5). Although CNR did not change in
ngiographically normal segments between the
cute and chronic phase of infarction, stenotic
egments revealed a significant decrease in signal
ntensity (CNR 6.8  5.0 vs. 10.9  3.8, p 
.002) and spatial extent of hyperenhanced seg-
ents (25% vs. 70%, p  0.01) (Fig. 5). For the
escending aortic vessel wall, a mean CNR of 10.3
6.4 was measured, which was not significantly
ifferent from the acute post-infarct phase.
I S C U S S I O N
o the best of our knowledge, this is the first study
f serial assessment of the coronary artery wall in
nfarct patients by CE-CMR using a gadolinium-
ased contrast medium. We found that in patients
arly after AMI, coronary wall contrast uptake is
ignificantly increased as compared with normal
ubjects, and correlates with the degree of lumen
arrowing by X-ray angiography. CE-CMR 3
onths after AMI revealed a significant reduction
f contrast uptake in stenotic segments, and the
verall systemic inflammatory activity was de-
reased as measured by CRP. The observed CE-
MR contrast pattern during the post-infarction
eriod may be associated with transient inflamma-
ion or edema in the pathologically altered coronary
essel wall.
E-CMR in advanced atherosclerosis. Atherosclerosis
s a chronic inflammatory disease of the vessel wall
ffecting different vascular regions such as the aorta,C
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Follow-up leukocyte
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Normal segments
Segments 25%
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585es. It is associated with endothelial activation,
ntimal thickening, extracellular matrix disorganiza-
ion, and accumulation of inflammatory cells
monocytes/macrophages, T cells), smooth muscle
ells, and low-density lipoproteins within the arte-
ial vessel wall (2). Gadolinium-based contrast me-
ia are nonspecific, and the underlying mechanisms
eading to contrast enhancement within the athero-
clerotic vessel wall are so far not fully elucidated.
hese agents are known to passively distribute from
he intravascular to the extracellular fluid space.
ontrast enhancement within atherosclerotic plaque
ay be due to increased wash-in, increased distri-
ution volume, and/or decreased washout of con-
rast agent molecules (11). The main components
f atherosclerotic plaques that may potentially con-
ribute to contrast enhancement are the extracellular
atrix (collagen, proteoglycans, elastic fibers), lip-
ds (cholesterol, phospholipids), and inflammation
macrophages, T lymphocytes).
CE-CMR and histology studies in patients with
dvanced carotid atherosclerosis have shown that
he enhancement pattern varies in different plaque
omponents (10,11). Strong enhancement is partic-
larly associated with fibrous plaque tissue whereas
Figure 4. Time Course of Coronary Enhancement
Infarct population: data are shown from a 55-year old patient with
between contrast enhancement and morphology, images were fuse
fact within the LCX. (A, E) CE-CMR 10 days after AMI displays diffus
ascending and descending aorta. The C-reactive protein (CRP) at th
displays a marked decrease of hyperenhancement within the ascen
the LAD while CRP returned to normal levels. (C) Coronary MRA of
ng/ml) shows a luminal stenosis within the proximal LAD (arrow) th
MRA 5 days after infarction revealed contrast uptake within the ent
nary enhancement was markedly reduced within the proximal LAD
CRP levels were normal at the follow-up scan. Abbreviations as in Fhe necrotic core only minimally enhances (10). rE-CMR enhancement of fibrosis has been exten-
ively described in various organ systems and is
linically commonly used to assess myocardial via-
ility in patients with chronic CAD (22). Prelimi-
ary data in patients with stable CAD that com-
ared CE-CMR with CT-findings have indicated
hat contrast enhancement occurs in fibrous-rich
nd calcified coronary plaques (14,15). Although
hese studies did not directly compare CE-CMR
ith histology, it is likely that the observed contrast
nhancement may be related to fibrosis as has been
escribed in atherosclerotic carotid artery tissue.
E-CMR 6 days after AMI. In this study, we demon-
trated that patients with AMI display a signifi-
antly increased contrast enhancement of the coro-
ary artery wall as compared with aged-matched
ubjects without CAD. When coronary segments
ere classified according to X-ray angiography,
here was higher enhancement among stenotic
25%) segments, which increased with the degree
f luminal stenosis. Our data are in agreement with
hose of previous studies in patients with stable
AD that also demonstrated progressive coronary
nhancement with increasing severity of atheroscle-
ral AMI (troponin T 7.3 ng/ml). To highlight the relationship
A) Coronary MRA of the left coronary system shows a stent arti-
ntrast uptake within the proximal LAD and LCX as well as in the
me was 3.7 mg/dl. (B, F) Follow-up CE-CMR 3 months after AMI
and descending aorta, the LCX, and to a lesser degree, within
-year-old patient with inferolateral infarction (troponin T 2.0
orresponds to a 50% stenosis on X-ray angiography. (C, G) CE-
roximal LAD (CRP 3.5 mg/dl). (D, H) Four months after AMI, coro-
le the stenotic region still showed some enhancement (arrows).
e 2.late
d. (
e co
at ti
ding
a 62
at c
ire p
whiosis (15).
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586E-CMR 3 months after AMI. Probably the most in-
eresting observation of this study was the decrease
f contrast enhancement within the coronary vessel
all at the 3-month post-infarction scan, whereas
o significant change of contrast enhancement was
ound in the aortic vessel wall. Because of the short
eriod between both CE-CMR studies, it is not
ery likely that this finding is related to plaque
olume regression but rather is associated with a
egression of systemic inflammation.
Vessel wall enhancement by CE-CMR has been
p<0.002
Normal <25% >25%
p<0.01
Normal <25% >25%
Segmental CE-CMR Coronary Artery Wall Enhancement
contrast-enhanced cardiac magnetic resonance (CE-CMR) coronary
enhancement in patients 6 days (baseline) (brown bars) and 3
llow-up) (orange bars) after myocardial infarction according to X-ray
y ﬁndings. (Top) At baseline, coronary contrast enhancement signiﬁ-
lated with the angiographic severity of lumen narrowing (p 
ollow-up, a signiﬁcant decrease in hyperenhancement was noted in
oronary segments, while normal segments showed no changes. (Bot-
lence of hyperenhancement signiﬁcantly decreased in stenotic seg-
een baseline and follow-up CE-CMR.bserved in various inflammatory disorders of the sascular system such as Takayasu’s arteritis (17) or
uperficial temporal arteritis (16), and serial CE-
MR has been successfully used in other organ
ystems for the characterization of inflammatory
ctivity. For instance, patients with myocarditis
emonstrated a myocardial contrast enhancement
n areas of acute inflammation that decreased on
ollow-up CE-CMR during the chronic stage of
isease (23).
The increased CRP levels in our study popula-
ion at baseline declined during the post-infarction
eriod, which may further support a potential link
etween inflammation or edema and the CE-CMR
ndings. Inflammation is recognized as a major
ontributor to the acute manifestations of athero-
clerosis (24), and elevation of inflammatory mark-
rs such as CRP is a common finding in ACS (25).
owever, whether CRP release in the acute setting
s directly related to vascular inflammation or pre-
ominantly a response to myocardial necrosis is
ubject to debate (26). It, therefore, remains unclear
hether the tissue signal changes measured are due
o vascular inflammation or edema, or whether it is
secondary effect to AMI.
imitations of CE-CMR. As inflammation (16), edema
27), and fibrosis (22) are associated with hyperen-
ancement using extracellular contrast agents, dif-
erentiation based on the visual appearance remains
ifficult. Differentiation between these conditions
ay be potentially possible using differences in the
harmacokinetics of contrast wash-in and wash-
ut. For instance, early and dynamic post-contrast
maging may be helpful to characterize inflamma-
ion due to the increased permeability and wash-in
28). Further studies are warranted that account for
pecific timing of CMR after contrast application.
oreover, the development of new magnetic reso-
ance contrast agents that allow the targeted imag-
ng of plaque components associated with inflam-
ation (29,30) or the confirmation of these
ndings with macrophage-targeting iron oxides
31) will give further insights in the characterization
f coronary atherosclerotic lesions in the future.
tudy limitations. Patients with AMI were not im-
ged by CE-CMR before intervention for ethical
easons. Therefore, the underlying culprit lesion
eading to infarction could not be evaluated in this
tudy. Additionally, CE-CMR was not compared
ith intravascular ultrasound (IVUS), the current
linical gold standard for in vivo assessment of
oronary plaque. Furthermore, it remains unclear
hether the enhancement of the vessel wall ob-C
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587dema, as no histologic specimens could be
btained.
Because of stent artifacts, the overall percentage
f segments that could be evaluated by CE-CMR
as reduced in patients with AMI. However, the
nability of CMR in the assessment of coronary
rtery segments with bare-metal or drug-eluting
tents is a general problem of CMR that might be
olved by the use of MR lucent stents in the future
32).
O N C L U S I O N S
n this study, we demonstrate a significant regres-
ion of coronary vessel wall enhancement in stenotic
egments during the post-infarction period in pa-inger KV, Manning WJ, Botnar RM. slice computed tomRP. Thus, serial CE-CMR may be useful for the
ssessment of tissue signal changes, which may
epresent transient coronary inflammation or edema
n the post-infarction period. In addition, CE-
MR may offer the potential to visualize tissue
ignal changes, which potentially represent inflam-
atory activity or edema in atherosclerosis associ-
ted with ACS. Larger studies are now warranted
o better understand the temporal and spatial
hange of coronary hyperenhancement by CE-
MR in patients with ACS and to understand its
linical impact.
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